
Read More
This Multibagger Pharma Giant’s Subsidiary Becomes First Fully NABL Accredi...
Over the past year, the stock has delivered a return of 27.39 per cent, while the three-year return ...

Over the past year, the stock has delivered a return of 27.39 per cent, while the three-year return ...

The Company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing F...

The company has consistently maintained a robust dividend payout ratio of 18.2 per cent. ...

The company has delivered returns of 41.8 per cent over the past year....

A global pharmaceutical company, has announced the launch of Thiamine Hydrochloride Injection USP, f...

Watch out for these large-cap stocks in Thursday’s trading session!...

Stock closed after a strong surge of 3.59 per cent from its previous day's close....

Watch out for these stocks in Monday’s trading session!...

Watch out for these stocks in Tuesday's trading session!...